hidocdr.com
Open in
urlscan Pro
18.239.50.83
Public Scan
Submitted URL: https://www.hidocdr.com/
Effective URL: https://hidocdr.com/
Submission: On December 21 via api from US — Scanned from DE
Effective URL: https://hidocdr.com/
Submission: On December 21 via api from US — Scanned from DE
Form analysis 0 forms found in the DOM
Text Content
You need to enable JavaScript to run this app. Drugs | Drug Database Drug Interaction Articles |News |Quizzes |Surveys |Diseases DatabaseClinical TrialsWebinars|Guidelines|Podcasts|Conferences -------------------------------------------------------------------------------- ☰ Hidoc Dr. (Global) YOUR ONE-STOP SOLUTION FOR MEDICAL LEARNING & UPDATES Fastest Growing Medical Platform for Doctors Total Global Active Health Care Professionals: 2.7M+ Today's News * A REAL-WORLD TYPE 1 DIABETES STUDY DEMONSTRATES THAT DAPAGLIFLOZIN IS APPROPRIATELY SAFE. Published Date: 21 Dec 2023 Dapagliflozin's suitable safety profile in the Dapa-ON trial was linked to the meticulous selection of individuals with T1D and the application of risk-reduction tactics. * ADVERSE DISEASE EXPOSURE HAS NO EFFECT ON THE RISK OF LATENT AUTOIMMUNE DIABETES IN ADULTS. Published Date: 21 Dec 2023 Infectious disease and type 1 diabetes are known to be associated, but the results had no effect on the risk of latent autoimmune diabetes in adults. * AN EXPLANATION OF EPICUTANEOUS IMMUNOTHERAPY FOR TODDLERS WITH PEANUT ALLERGIES. Published Date: 21 Dec 2023 Epicutaneous immunotherapy using DBV 712 (Viaskin Peanut; DBV Technologies) is highlighted by a lead study investigator who also provides study details and an analysis of the treatment's potential, indications, and usability. * THERE IS NO CONNECTION BETWEEN TYPE 1 DIABETES IN CHILDREN AND MENTAL HEALTH ISSUES IN MOTHERS. Published Date: 21 Dec 2023 A recent study found no correlation between a mother's mood disorders—major depressive disorder, bipolar disorder, or schizophrenia/schizoaffective disorder—and the risk of type 1 diabetes in her offspring. * OMAVELOXOLONE IS THE FIRST EU-APPROVED TREATMENT FOR FRIEDREICH ATAXIA, AND THE CHMP HAS A POSITIVE OPINION OF IT. Published Date: 21 Dec 2023 Using the modified Friedreich Ataxia Rating Scale, patients on omaveloxolone showed less physical impairment than patients receiving a placebo in a phase 3 study. * WITH THE MODIFICATION OF ADVANCED THERAPIES, THE SYMPTOMS OF PARKINSON'S DISEASE IMPROVED. Published Date: 21 Dec 2023 It is important to consider combination therapies when efficacy declines or adverse events occur. A recent retrospective analysis found that modifying advanced therapies improved motor and subjective symptoms. * A PARADIGM CHANGE IN THE TREATMENT OF PARKINSON'S DISEASE'S NON-MOTOR SYMPTOMS. Published Date: 21 Dec 2023 The knowledgeable neurologists talk about the different kinds of non-motor symptoms of Parkinson's disease, how they affect patients' quality of life, and new and existing treatments for these symptoms. * INVESTIGATION UNCOVERS FUNDAMENTAL IDEAS FOR ENHANCING PALLIATIVE CARE FOR PARKINSON'S PATIENTS. Published Date: 21 Dec 2023 Integrating, coordinating, and creating customized care plans are key components of a recent systematic practice review's practical suggestions for improving palliative care for Parkinson disease patients and their carers. * FRIEDREICH ATAXIA: A CASE STUDY SHOWS A NOVEL INTRAGENIC DELETION OF THE FXN GENE. Published Date: 21 Dec 2023 A novel intragenic deletion affecting the 5'UTR upstream region and exons 1 and 2 of the FXN gene was discovered through parental sample testing in a recent case study of a 32-year-old man with Friedreich ataxia. * REPORT: THE MAJORITY OF ADULTS DO NOT RECOGNIZE DIABETES AS A RISK FACTOR FOR CARDIOVASCULAR DISEASE. Published Date: 21 Dec 2023 Adults in middle- to high-income countries continue to struggle with understanding diabetes as a cardiovascular risk factor. * A REAL-WORLD TYPE 1 DIABETES STUDY DEMONSTRATES THAT DAPAGLIFLOZIN IS APPROPRIATELY SAFE. Published Date: 21 Dec 2023 Dapagliflozin's suitable safety profile in the Dapa-ON trial was linked to the meticulous selection of individuals with T1D and the application of risk-reduction tactics. * ADVERSE DISEASE EXPOSURE HAS NO EFFECT ON THE RISK OF LATENT AUTOIMMUNE DIABETES IN ADULTS. Published Date: 21 Dec 2023 Infectious disease and type 1 diabetes are known to be associated, but the results had no effect on the risk of latent autoimmune diabetes in adults. * AN EXPLANATION OF EPICUTANEOUS IMMUNOTHERAPY FOR TODDLERS WITH PEANUT ALLERGIES. Published Date: 21 Dec 2023 Epicutaneous immunotherapy using DBV 712 (Viaskin Peanut; DBV Technologies) is highlighted by a lead study investigator who also provides study details and an analysis of the treatment's potential, indications, and usability. * THERE IS NO CONNECTION BETWEEN TYPE 1 DIABETES IN CHILDREN AND MENTAL HEALTH ISSUES IN MOTHERS. Published Date: 21 Dec 2023 A recent study found no correlation between a mother's mood disorders—major depressive disorder, bipolar disorder, or schizophrenia/schizoaffective disorder—and the risk of type 1 diabetes in her offspring. AN EXPLANATION OF EPICUTANEOUS IMMUNOTHERAPY FOR TODDLERS WITH PEANUT ALLERGIES. Published Date: 21 Dec 2023 Epicutaneous immunotherapy using DBV 712 (Viaskin Peanut; DBV Technologies) is highlighted by a lead study investigator who also provides study details and an analysis of the treatment's potential, indications, and usability. Sign Up Now THERE IS NO CONNECTION BETWEEN TYPE 1 DIABETES IN CHILDREN AND MENTAL HEALTH ISSUES IN MOTHERS. Published Date: 21 Dec 2023 A recent study found no correlation between a mother's mood disorders—major depressive disorder, bipolar disorder, or schizophrenia/schizoaffective disorder—and the risk of type 1 diabetes in her offspring. OMAVELOXOLONE IS THE FIRST EU-APPROVED TREATMENT FOR FRIEDREICH ATAXIA, AND THE CHMP HAS A POSITIVE OPINION OF IT. Published Date: 21 Dec 2023 Using the modified Friedreich Ataxia Rating Scale, patients on omaveloxolone showed less physical impairment than patients receiving a placebo in a phase 3 study. WITH THE MODIFICATION OF ADVANCED THERAPIES, THE SYMPTOMS OF PARKINSON'S DISEASE IMPROVED. Published Date: 21 Dec 2023 It is important to consider combination therapies when efficacy declines or adverse events occur. A recent retrospective analysis found that modifying advanced therapies improved motor and subjective symptoms. A PARADIGM CHANGE IN THE TREATMENT OF PARKINSON'S DISEASE'S NON-MOTOR SYMPTOMS. Published Date: 21 Dec 2023 The knowledgeable neurologists talk about the different kinds of non-motor symptoms of Parkinson's disease, how they affect patients' quality of life, and new and existing treatments for these symptoms. View All News ARTICLES -------------------------------------------------------------------------------- All Speciality • 21 Dec 2023 DO MICROSCOPIC NEMATODE WORMS HELP IN CANCER DETECTION? The unique ability of nematodes to sense subtle chemical changes has led to the development of novel cancer tests, sparking intrigue and debate. All Speciality • 21 Dec 2023 HOW THE NEW COUMARIN ANTIBIOTIC CAN HELP CANCER PATIENTS? The fight against cancer continues to evolve, demanding novel therapeutic approaches to combat this complex and multifaceted disease. -------------------------------------------------------------------------------- All Speciality • 21 Dec 2023 WHY NEURAXIAL ANESTHESIA REIGNS SUPREME IN ORTHOPEDIC SURGERY? Orthopedic surgery, encompassing a wide range of procedures from joint replacements to spinal fusions, often necessitates robust pain management. All Speciality • 18 Dec 2023 UNVEILING THE HIDDEN INFLUENCE: AGE-DEPENDENT EFFECTS OF ANESTHESIA AND SURGERY ON BEHAVIOR AND MICROBIOTA The age-dependent impact of anesthesia and surgery on post-operative outcomes remains a fascinating and complex puzzle. All Speciality • 18 Dec 2023 YOGURT THERAPY FOR SCHIZOPHRENIA: EXPLORING THE GUT-BRAIN AXIS CONNECTION Schizophrenia, a chronic and debilitating mental illness, is characterized by altered perceptions, delusions, and disorganized thinking. All Speciality • 18 Dec 2023 UNVEILING THE FUTURE: ARTIFICIAL INTELLIGENCE IN DIAGNOSING NEONATAL METABOLIC DISORDERS Neonatal metabolic disorders (NMDs) present a complex diagnostic challenge, often leading to delayed identification. All Speciality • 15 Dec 2023 MANAGING ASYMMETRIC LIMB HYPERTROPHY AND DIFFUSE CAPILLARY MALFORMATIONS IN LOEYS-DIETZ SYNDROME TYPE 3: A REVIEW OF CURRENT APPROACHES Loeys-Dietz syndrome type 3 (LDS3) presents a unique challenge for management due to its complex manifestations. All Speciality • 15 Dec 2023 CRISPR-CAS9 GENE THERAPY FOR SICKLE CELL DISEASE: TURNING HOPE INTO REALITY Sickle cell disease (SCD) is a debilitating inherited blood disorder characterized by red blood cells adopting a rigid, sickle-shaped form. All Speciality • 15 Dec 2023 THE LIDOCAINE ADVANTAGE? COMPARING ADD-ONS FOR POST-INTUBATION SORE THROAT PREVENTION Sore throat is a common and often distressing complication after laryngoscopy and endotracheal intubation (ETI), occurring in up to 70% of patients All Speciality • 04 Dec 2023 HOW DOES NITROUS OXIDE IMPACT CLINICAL OUTCOMES IN PATIENTS UNDERGOING CEREBELLOPONTINE TUMOR SURGERY UNDER SEVOFLURANE ANESTHESIA? -------------------------------------------------------------------------------- All Speciality • 04 Dec 2023 AI-POWERED PRECISION MEDICINE: TRANSFORMING PHYSICIAN APPROACHES IN DERMATOLOGY, GASTROENTEROLOGY, AND BEYOND -------------------------------------------------------------------------------- All Speciality • 04 Dec 2023 HOW DOES A MACHINE LEARNING MODEL HELP IN THE EARLY PREDICTION OF ACUTE KIDNEY INJURY (AKI) IN PEDIATRIC CRITICAL CARE? -------------------------------------------------------------------------------- All Speciality • 01 Dec 2023 HOW DO GENETIC AND EPIGENETIC REGULATION IMPACT HUMAN PAPILLOMAVIRUS AND APOPTOSIS IN CERVICAL AND LUNG CANCER? -------------------------------------------------------------------------------- All Speciality • 01 Dec 2023 HOW ARTIFICIAL INTELLIGENCE EMPOWERS PHYSICIANS IN BLADDER CANCER MANAGEMENT? -------------------------------------------------------------------------------- All Speciality • 01 Dec 2023 COMBATING BONE LOSS IN INFLAMMATORY BOWEL DISEASE: EXOSOME-BASED DRUG DELIVERY TO THE RESCUE -------------------------------------------------------------------------------- View All Articles WEBINARS -------------------------------------------------------------------------------- THE LIFESAVING POWER OF INFLUENZA VACCINES FOR DIABETIC INDIVIDUALS Dr. Sanjay Agarwal and 1 more THE ADVANTAGES OF CDK4/6 INHIBITORS IN HR+/ HER2-ABC CLINICAL TRIALS Dr. Bhavna Parikh and 4 more THE VITAL IMPORTANCE OF INFLUENZA VACCINATION FOR DIABETES AND COPD PATIENTS Dr. Vinay D and 1 more SERONEGATIVE RHEUMATOID ARTHRITIS IS RA OR NOT- WHAT DO YOU THINK? Dr Vijay KR Rao View All Webinars QUIZZES -------------------------------------------------------------------------------- Quiz on Atrial Fibrillation Quiz On Rubella Disease Quiz On Shingles Disease Quiz On Pneumococcal Disease Quiz On Wilson's Disease Quiz On Legionnaires Disease View All Quizzes SURVEYS -------------------------------------------------------------------------------- Survey on skin rashes Survey on dandruff Survey on Viral Hepatitis Survey on Use of AI in Health and Medicine Survey on VTE View All Surveys Fastest Growing Medical Platform for Doctors. About Hidoc Dr REACH US Please contact the below details for any other information Email: global@hidocdr.com Address: Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801 HIDOC DR. FEATURES Drug Database Webinars Drug Interaction Medical Calculator Articles Quizzes Diseases Database Surveys © Copyright 2023 Hidoc Dr. Inc. Terms & Conditions | Privacy Policy Home Profile Login By using this site, you agree with our use of cookies. Accept Cookies